View Future GrowthSOL 過去の業績過去 基準チェック /56SOLは、平均年間10.4%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間4.4% 11.6%収益成長率で 成長しています。 SOLの自己資本利益率は14.8%であり、純利益率は9.2%です。主要情報10.36%収益成長率10.36%EPS成長率Chemicals 業界の成長12.41%収益成長率11.57%株主資本利益率14.79%ネット・マージン9.23%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €59.40, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 145% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.91 per share.お知らせ • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.3% average weekly change).Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).New Risk • Mar 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.2%).Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Apr 08SOL S.p.A. announced that it has received €75 million in funding from The Prudential Insurance Company of America, Prudential Legacy Insurance Company of New Jersey, Prudential Term Reinsurance Company, Pruco Life Insurance Company, Gibraltar Universal Life Reinsurance CompanyOn April 6, 2022, SOL S.p.A. closed the transaction.Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 18Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).Is New 90 Day High Low • Feb 19New 90-day high: €15.55The company is up 30% from its price of €11.95 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.Is New 90 Day High Low • Jan 26New 90-day high: €14.25The company is up 31% from its price of €10.90 on 27 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.Is New 90 Day High Low • Jan 05New 90-day high: €14.10The company is up 18% from its price of €12.00 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Is New 90 Day High Low • Dec 07New 90-day high: €12.90The company is up 25% from its price of €10.35 on 08 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Nov 19New 90-day high: €12.05The company is up 15% from its price of €10.45 on 21 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.Is New 90 Day High Low • Oct 07New 90-day high: €12.00The company is up 17% from its price of €10.30 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Sep 18New 90-day high: €11.15The company is up 9.0% from its price of €10.20 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.収支内訳SOL の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史BST:QOL 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 251,810167384030 Sep 251,776162192030 Jun 251,7351560031 Mar 251,6871520031 Dec 241,6401480030 Sep 241,5971440030 Jun 241,5631410031 Mar 241,5441430031 Dec 231,5251460030 Sep 231,5051470030 Jun 231,4851490031 Mar 231,4551410031 Dec 221,4251340030 Sep 221,3461190030 Jun 221,2661040031 Mar 221,199970031 Dec 211,132900030 Sep 211,0941020030 Jun 211,0561150031 Mar 211,0221090031 Dec 209871030030 Sep 20966830030 Jun 20945650031 Mar 20932590031 Dec 19919520030 Sep 19899490030 Jun 19880490031 Mar 19863510031 Dec 18845520030 Sep 18828520030 Jun 18810510031 Mar 18789460031 Dec 17768400030 Sep 17752410030 Jun 17736420031 Mar 17726430031 Dec 16715440030 Sep 16708400030 Jun 16702350031 Mar 16695340031 Dec 15689320030 Sep 15683310030 Jun 156773000質の高い収益: QOLは 高品質の収益 を持っています。利益率の向上: QOLの現在の純利益率 (9.2%)は、昨年(9%)よりも高くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: QOLの収益は過去 5 年間で年間10.4%増加しました。成長の加速: QOLの過去 1 年間の収益成長率 ( 13.1% ) は、5 年間の平均 ( 年間10.4%を上回っています。収益対業界: QOLの過去 1 年間の収益成長率 ( 13.1% ) はChemicals業界-2.4%を上回りました。株主資本利益率高いROE: QOLの 自己資本利益率 ( 14.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 19:23終値2026/05/06 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SOL S.p.A. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。7 アナリスト機関Paola SagliettiBanca Akros S.p.A. (ESN)Davide ZappaBanca Akros S.p.A. (ESN)Catharina ClaesBerenberg4 その他のアナリストを表示
Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 22%After last week's 22% share price gain to €59.40, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 14x in the Chemicals industry in Germany. Total returns to shareholders of 145% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.91 per share.
お知らせ • Mar 30SOL S.p.A., Annual General Meeting, May 12, 2026SOL S.p.A., Annual General Meeting, May 12, 2026, at 11:00 W. Europe Standard Time.
Reported Earnings • Mar 30Full year 2025 earnings released: EPS: €1.84 (vs €1.63 in FY 2024)Full year 2025 results: EPS: €1.84 (up from €1.63 in FY 2024). Revenue: €1.81b (up 10% from FY 2024). Net income: €167.0m (up 13% from FY 2024). Profit margin: 9.2% (up from 9.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 27SOL S.p.A. announces Annual dividend, payable on May 20, 2026SOL S.p.A. announced Annual dividend of EUR 0.4500 per share payable on May 20, 2026, ex-date on May 18, 2026 and record date on May 19, 2026.
New Risk • Sep 18New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 49% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (49% net debt to equity). Share price has been volatile over the past 3 months (7.3% average weekly change).
Reported Earnings • Sep 15First half 2025 earnings released: EPS: €0.92 (vs €0.83 in 1H 2024)First half 2025 results: EPS: €0.92 (up from €0.83 in 1H 2024). Revenue: €890.2m (up 13% from 1H 2024). Net income: €83.5m (up 12% from 1H 2024). Profit margin: 9.4% (in line with 1H 2024). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 46% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • May 12Upcoming dividend of €0.39 per shareEligible shareholders must have bought the stock before 19 May 2025. Payment date: 21 May 2025. Trailing yield: 0.9%. Lower than top quartile of German dividend payers (4.3%). Lower than average of industry peers (3.9%).
Declared Dividend • Mar 31Dividend increased to €0.39Dividend of €0.39 is 5.4% higher than last year. Ex-date: 19th May 2025 Payment date: 21st May 2025 Dividend yield will be 1.1%, which is lower than the industry average of 6.1%. Sustainability & Growth The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 32% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 30SOL S.p.A. announces Annual dividend, payable on May 21, 2025SOL S.p.A. announced Annual dividend of EUR 0.3900 per share payable on May 21, 2025, ex-date on May 19, 2025 and record date on May 20, 2025.
Reported Earnings • Mar 30Full year 2024 earnings released: EPS: €1.63 (vs €1.61 in FY 2023)Full year 2024 results: EPS: €1.63 (up from €1.61 in FY 2023). Revenue: €1.64b (up 9.3% from FY 2023). Net income: €147.7m (up 1.3% from FY 2023). Profit margin: 9.0% (in line with FY 2023). Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 31% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 17First half 2024 earnings released: EPS: €0.83 (vs €0.88 in 1H 2023)First half 2024 results: EPS: €0.83 (down from €0.88 in 1H 2023). Revenue: €779.6m (up 3.0% from 1H 2023). Net income: €74.9m (down 5.9% from 1H 2023). Profit margin: 9.6% (in line with 1H 2023). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 19% per year.
Upcoming Dividend • May 13Upcoming dividend of €0.37 per shareEligible shareholders must have bought the stock before 20 May 2024. Payment date: 22 May 2024. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of German dividend payers (4.6%). Lower than average of industry peers (5.0%).
New Risk • Mar 28New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 45% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: €1.61 (vs €1.47 in FY 2022)Full year 2023 results: EPS: €1.61 (up from €1.47 in FY 2022). Revenue: €1.53b (up 5.4% from FY 2022). Net income: €145.7m (up 9.0% from FY 2022). Profit margin: 9.5% (in line with FY 2022). Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Sep 20Second quarter 2023 earnings released: EPS: €0.42 (vs €0.35 in 2Q 2022)Second quarter 2023 results: EPS: €0.42 (up from €0.35 in 2Q 2022). Revenue: €378.9m (up 11% from 2Q 2022). Net income: €38.5m (up 20% from 2Q 2022). Profit margin: 10% (in line with 2Q 2022). Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 2.0% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Sep 17New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 47% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. This is currently the only risk that has been identified for the company.
Upcoming Dividend • May 15Upcoming dividend of €0.33 per share at 1.2% yieldEligible shareholders must have bought the stock before 22 May 2023. Payment date: 24 May 2023. Payout ratio is a comfortable 22% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (4.7%). Lower than average of industry peers (5.6%).
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 11 experienced directors. No highly experienced directors. 5 independent directors (6 non-independent directors). Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Sep 18Second quarter 2022 earnings released: EPS: €0.35 (vs €0.26 in 2Q 2021)Second quarter 2022 results: EPS: €0.35 (up from €0.26 in 2Q 2021). Revenue: €357.9m (up 28% from 2Q 2021). Net income: €32.1m (up 36% from 2Q 2021). Profit margin: 9.0% (up from 8.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 09Upcoming dividend of €0.24 per shareEligible shareholders must have bought the stock before 16 May 2022. Payment date: 18 May 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.2%). Lower than average of industry peers (5.2%).
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 5 independent directors on the board. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Erwin Paul Rauhe was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 08SOL S.p.A. announced that it has received €75 million in funding from The Prudential Insurance Company of America, Prudential Legacy Insurance Company of New Jersey, Prudential Term Reinsurance Company, Pruco Life Insurance Company, Gibraltar Universal Life Reinsurance CompanyOn April 6, 2022, SOL S.p.A. closed the transaction.
Reported Earnings • Sep 18Second quarter 2021 earnings released: EPS €0.26 (vs €0.23 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: €280.7m (up 17% from 2Q 2020). Net income: €23.7m (up 15% from 2Q 2020). Profit margin: 8.4% (down from 8.6% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 18Full year 2020 earnings released: EPS €1.19 (vs €0.58 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €987.1m (up 7.5% from FY 2019). Net income: €108.2m (up 107% from FY 2019). Profit margin: 11% (up from 5.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • May 17Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 24 May 2021. Payment date: 26 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.3%). Lower than average of industry peers (3.6%).
Upcoming Dividend • May 10Upcoming dividend of €0.22 per shareEligible shareholders must have bought the stock before 17 May 2021. Payment date: 19 May 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.2%). Lower than average of industry peers (3.5%).
Is New 90 Day High Low • Feb 19New 90-day high: €15.55The company is up 30% from its price of €11.95 on 20 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period.
Is New 90 Day High Low • Jan 26New 90-day high: €14.25The company is up 31% from its price of €10.90 on 27 October 2020. The German market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.
Is New 90 Day High Low • Jan 05New 90-day high: €14.10The company is up 18% from its price of €12.00 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Is New 90 Day High Low • Dec 07New 90-day high: €12.90The company is up 25% from its price of €10.35 on 08 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Nov 19New 90-day high: €12.05The company is up 15% from its price of €10.45 on 21 August 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period.
Is New 90 Day High Low • Oct 07New 90-day high: €12.00The company is up 17% from its price of €10.30 on 09 July 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Sep 18New 90-day high: €11.15The company is up 9.0% from its price of €10.20 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period.